These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. An extensive and diverse set of molecular overlays for the validation of pharmacophore programs. Giangreco I; Cosgrove DA; Packer MJ J Chem Inf Model; 2013 Apr; 53(4):852-66. PubMed ID: 23565904 [TBL] [Abstract][Full Text] [Related]
23. Computational Biology and Chemistry in MTi: Emphasis on the Prediction of Some ADMET Properties. Miteva MA; Villoutreix BO Mol Inform; 2017 Oct; 36(10):. PubMed ID: 28221002 [TBL] [Abstract][Full Text] [Related]
24. Discovery of new human epidermal growth factor receptor-2 (HER2) inhibitors for potential use as anticancer agents via ligand-based pharmacophore modeling. Zalloum H; Tayyem R; Irmaileh BA; Bustanji Y; Zihlif M; Mohammad M; Rjai TA; Mubarak MS J Mol Graph Model; 2015 Sep; 61():61-84. PubMed ID: 26188796 [TBL] [Abstract][Full Text] [Related]
25. Rchemcpp: a web service for structural analoging in ChEMBL, Drugbank and the Connectivity Map. Klambauer G; Wischenbart M; Mahr M; Unterthiner T; Mayr A; Hochreiter S Bioinformatics; 2015 Oct; 31(20):3392-4. PubMed ID: 26088801 [TBL] [Abstract][Full Text] [Related]
26. BindingDB and ChEMBL: online compound databases for drug discovery. Wassermann AM; Bajorath J Expert Opin Drug Discov; 2011 Jul; 6(7):683-7. PubMed ID: 22650976 [TBL] [Abstract][Full Text] [Related]
27. DRUDIT: web-based DRUgs DIscovery Tools to design small molecules as modulators of biological targets. Lauria A; Mannino S; Gentile C; Mannino G; Martorana A; Peri D Bioinformatics; 2020 Mar; 36(5):1562-1569. PubMed ID: 31605102 [TBL] [Abstract][Full Text] [Related]
28. The importance of employing computational resources for the automation of drug discovery. Rosales-Hernández MC; Correa-Basurto J Expert Opin Drug Discov; 2015 Mar; 10(3):213-9. PubMed ID: 25682781 [TBL] [Abstract][Full Text] [Related]
29. Using Cheminformatics in Drug Discovery. Lawless MS; Waldman M; Fraczkiewicz R; Clark RD Handb Exp Pharmacol; 2016; 232():139-68. PubMed ID: 26318607 [TBL] [Abstract][Full Text] [Related]
30. In silico exploration of c-KIT inhibitors by pharmaco-informatics methodology: pharmacophore modeling, 3D QSAR, docking studies, and virtual screening. Chaudhari P; Bari S Mol Divers; 2016 Feb; 20(1):41-53. PubMed ID: 26416560 [TBL] [Abstract][Full Text] [Related]
31. Grid-Based Technologies for In Silico Screening and Drug Design. Potemkin V; Grishina M Curr Med Chem; 2018; 25(29):3526-3537. PubMed ID: 29521207 [TBL] [Abstract][Full Text] [Related]
32. DT-Web: a web-based application for drug-target interaction and drug combination prediction through domain-tuned network-based inference. Alaimo S; Bonnici V; Cancemi D; Ferro A; Giugno R; Pulvirenti A BMC Syst Biol; 2015; 9 Suppl 3(Suppl 3):S4. PubMed ID: 26050742 [TBL] [Abstract][Full Text] [Related]
33. Toward in silico structure-based ADMET prediction in drug discovery. Moroy G; Martiny VY; Vayer P; Villoutreix BO; Miteva MA Drug Discov Today; 2012 Jan; 17(1-2):44-55. PubMed ID: 22056716 [TBL] [Abstract][Full Text] [Related]
34. Quantitative structure-activity relationship: promising advances in drug discovery platforms. Wang T; Wu MB; Lin JP; Yang LR Expert Opin Drug Discov; 2015 Dec; 10(12):1283-300. PubMed ID: 26358617 [TBL] [Abstract][Full Text] [Related]
35. An OGSA-based integration of life-scientific resources for drug discovery. Kosaka T; Tohsato Y; Date S; Matsuda H; Shimojo S Methods Inf Med; 2005; 44(2):257-61. PubMed ID: 15924187 [TBL] [Abstract][Full Text] [Related]
37. Utility of protein structures in overcoming ADMET-related issues of drug-like compounds. Stoll F; Göller AH; Hillisch A Drug Discov Today; 2011 Jun; 16(11-12):530-8. PubMed ID: 21554979 [TBL] [Abstract][Full Text] [Related]
38. LIBP-Pred: web server for lipid binding proteins using structural network parameters; PDB mining of human cancer biomarkers and drug targets in parasites and bacteria. González-Díaz H; Munteanu CR; Postelnicu L; Prado-Prado F; Gestal M; Pazos A Mol Biosyst; 2012 Mar; 8(3):851-62. PubMed ID: 22234525 [TBL] [Abstract][Full Text] [Related]
39. ChEMBL web services: streamlining access to drug discovery data and utilities. Davies M; Nowotka M; Papadatos G; Dedman N; Gaulton A; Atkinson F; Bellis L; Overington JP Nucleic Acids Res; 2015 Jul; 43(W1):W612-20. PubMed ID: 25883136 [TBL] [Abstract][Full Text] [Related]
40. Computer-aided drug design to explore cyclodextrin therapeutics and biomedical applications. Abdolmaleki A; Ghasemi F; Ghasemi JB Chem Biol Drug Des; 2017 Feb; 89(2):257-268. PubMed ID: 28205401 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]